Aqua Bio Technology: Update on resolutions for general meeting - Cancellation of Subsequent Offering

11 Nov 2024 23:31 CET

11.11.2024 23:31:20 CET | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

Reference is made to the notice for an extraordinary general meeting in Aqua Bio
Technology ASA (the "Company") published on 23 October 2024, and to the private
placement of new shares in the Company (the "Private Placement") that was
announced placed on 18 October, and to the contemplated subsequent offering of
new shares following the Private Placement (the "Subsequent Offering").



The Company's auditor has prepared an independent expert report in connection
with the Private Placement, which is attached to this stock exchange notice, and
forms part of the decision material for the general meeting. In connection with
the Private Placement, the Board has also amended its proposal with respect to
the Private Placement where the share capital shall be increased with NOK
98,408,672.50 through issuance of 39,363,469 new shares, i.e. one share less
than stated in the notice for the extraordinary general meeting. The reason for
the amended proposal is an updated counting of certain receivables to be
converted to new shares in the Private Placement.



Further, the Board of the Company has decided to withdraw the proposal for share
capital increase in connection with the Subsequent Offering of up to 2,000,000
new shares, as in the period following announcement of the Private Placement it
has been traded more than 2,000,000 shares in the Company over the stock
exchange and at lower average prices than the subscription price in the
Subsequent Offering of NOK 3 per share. Shareholders that have wanted to limit
their dilution following the Private Placement has thus been able to do so
through purchase of shares in the open market.



For further information, please contact Jan Varming, CFO, telephone +47 90 83 90
76.



This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.



About Aqua Bio Technology ASA



Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT's cosmetics ingredients are
highly effective, and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skincare products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company's strategy going forward. ABT is listed on the
Euronext Expand market of the Oslo Stock Exchange.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Jan Aas Varming, CFO, Aqua Bio Technology ASA, +47 908 39 076,
jan@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18319603/5231/Download%20announce
ment%20as%20PDF.pdf

Sakkyndig_redegjorelse_ved_kapitalforhoyelse_ved_motregning_Aqua_Bio_Technology_
ASA_11-11-2024.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18319603/5230/Sakkyndig_redegjore
lse_ved_kapitalforhoyelse_ved_motregning_Aqua_Bio_Technology_ASA_11-11-2024.pdf

More information:
Access the news on Oslo Bors NewsWeb site

631874_Sakkyndig_redegjorelse_ved_kapitalforhoyelse_ved_motregning_Aqua_Bio_Technology_ASA_11-11-2024.pdf
631874_Download announcement as PDF.pdf